Trade Talis Biomedical Corporation - TLIS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024151% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001929% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.13 |
| Open | 4.15 |
| 1-Year Change | -33.28% |
| Day's Range | 3.95 - 4.38 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Aug 30, 2024 | 4.36 | 0.21 | 5.06% | 4.15 | 4.38 | 3.94 |
| Aug 29, 2024 | 4.13 | 0.06 | 1.47% | 4.07 | 4.38 | 4.06 |
| Aug 28, 2024 | 3.98 | 0.20 | 5.29% | 3.78 | 3.98 | 3.78 |
| Aug 27, 2024 | 3.83 | -0.09 | -2.30% | 3.92 | 3.92 | 3.72 |
| Aug 26, 2024 | 3.98 | 0.30 | 8.15% | 3.68 | 3.98 | 3.60 |
| Aug 23, 2024 | 4.36 | 0.32 | 7.92% | 4.04 | 4.38 | 4.04 |
| Aug 22, 2024 | 4.15 | -0.14 | -3.26% | 4.29 | 4.55 | 4.15 |
| Aug 21, 2024 | 4.26 | 0.13 | 3.15% | 4.13 | 4.33 | 4.13 |
| Aug 20, 2024 | 4.07 | 0.01 | 0.25% | 4.06 | 4.29 | 4.03 |
| Aug 19, 2024 | 4.39 | 0.00 | 0.00% | 4.39 | 4.43 | 4.28 |
| Aug 16, 2024 | 4.33 | 0.44 | 11.31% | 3.89 | 4.33 | 3.89 |
| Aug 15, 2024 | 4.07 | -0.01 | -0.25% | 4.08 | 4.13 | 3.99 |
| Aug 14, 2024 | 3.99 | 0.02 | 0.50% | 3.97 | 4.13 | 3.78 |
| Aug 13, 2024 | 4.03 | 0.19 | 4.95% | 3.84 | 4.03 | 3.84 |
| Aug 12, 2024 | 3.89 | 0.14 | 3.73% | 3.75 | 4.03 | 3.75 |
| Aug 9, 2024 | 3.73 | -0.22 | -5.57% | 3.95 | 4.25 | 3.70 |
| Aug 8, 2024 | 4.18 | -0.20 | -4.57% | 4.38 | 4.39 | 3.95 |
| Aug 7, 2024 | 4.53 | 0.05 | 1.12% | 4.48 | 4.94 | 4.10 |
| Aug 6, 2024 | 8.97 | 0.17 | 1.93% | 8.80 | 9.03 | 8.48 |
| Aug 5, 2024 | 8.68 | 0.15 | 1.76% | 8.53 | 8.97 | 8.38 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Talis Biomedical Corporation Company profile
About Talis Biomedical Corp
Talis Biomedical Corporation. (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. The Company is focused on developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions. Talis is developing the Talis One platform, a cloud-enabled molecular diagnostic platform. The Talis One platform comprises a compact instrument, single-use test cartridges and software, including a central cloud database, which work together and are designed to provide central laboratory levels of accuracy. The platform is designed for use in non-laboratory settings, such as physicians’ offices, hospital emergency departments, urgent care clinics, ambulatory surgery centers, assisted living facilities, and cancer treatment and dialysis centers. The Company is also developing Talis One tests for respiratory infections, infections related to women’s health and sexually transmitted infections.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Talis Biomedical Corp revenues decreased 25% to $8.2M. Net loss increased from $91.1M to $192M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Basic Earnings per Share excluding Extraordinary Items decreased from -$3.88 to -$7.30.
| Industry: | Biotechnology & Medical Research (NEC) |
1100 Island Drive
Suite 101
REDWOOD CITY
CALIFORNIA 94065
US
News
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024
US elections: Trump leads the polls, but tariff talk spooks investors
As the US elections get closer we look at how Trump’s tariff plans could affect markets.
15:02, 22 October 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com